Mi Y, Bian S, Chen G
Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Tianjin 300020.
Zhonghua Xue Ye Xue Za Zhi. 1999 Feb;20(2):76-8.
To analyse the expression of myeloid markers and CD34 antigen on lymphoblasts in adult ALL and its relationship with prognosis.
Immunophenotypes were examined using indirect immunofluorescence method in 102 de novo ALL.
The incidence of myeloid antigen expression in adult ALL was 21.6% and the commonest one was CD33 (15.7%). There was a higher incidence of myeloid antigens expression in ALL-L2 than in ALL-L1 (25.6% vs 5.3%, P = 0.05). CD34 was expressed in lymphoblasts from 30 of 56 patients (53.6%). Incidence of CD34 expression in B-ALL was higher than that in T-ALL (61.7% vs 11.1%, P < 0.01). No relationship between CD34, myeloid antigens and cell maturity was found within B-ALL. There was no relation between expression of myeloid antigens and CD34. The CR rate in My(+)-ALL was lower than that in My(-)-ALL (52.6% vs 80.0%, P < 0.025), and was no relation with CD34 expression. In addition, Ph chromosome and/or bcr/abl fusion gene was positive in 35.9% of the patients, and CR rate of Ph positive patients was higher than that in Ph negative patients.
Expression of myeloid antigens was related to FAB subtype and cell maturity in adult ALL. There was no relationship between myeloid antigen expression and CR rate. A higher incidence of CD34 expression was found in Pro-B-ALL than in common-ALL and Pre-B-ALL. Expression of CD34 had no relation with CR rate.
分析成人急性淋巴细胞白血病(ALL)中原始淋巴细胞上髓系标志物和CD34抗原的表达情况及其与预后的关系。
采用间接免疫荧光法检测102例初发ALL患者的免疫表型。
成人ALL中髓系抗原表达发生率为21.6%,最常见的是CD33(15.7%)。ALL-L2中髓系抗原表达发生率高于ALL-L1(25.6%对5.3%,P = 0.05)。56例患者中有30例(53.6%)的原始淋巴细胞表达CD34。B-ALL中CD34表达发生率高于T-ALL(61.7%对11.1%,P < 0.01)。在B-ALL中未发现CD34、髓系抗原与细胞成熟度之间的关系。髓系抗原表达与CD34之间无关联。My(+)-ALL的完全缓解(CR)率低于My(-)-ALL(52.6%对80.0%,P < 0.025),且与CD34表达无关。此外,35.9%的患者Ph染色体和/或bcr/abl融合基因呈阳性,Ph阳性患者的CR率高于Ph阴性患者。
成人ALL中髓系抗原表达与FAB亚型及细胞成熟度相关。髓系抗原表达与CR率无关。Pro-B-ALL中CD34表达发生率高于普通ALL和前B-ALL。CD34表达与CR率无关。